| 38041698 | Recommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task Force. | Pharmacoeconomics | 2024 |
| 37945777 | A Systematic Review of Methods Used by Pediatric Cost-Utility Analyses to Include Family Spillover Effects. | Pharmacoeconomics | 2024 |
| 36336350 | Stress, anxiety, depression, and health-related quality of life in caregivers of children with intestinal failure receiving parenteral nutrition: A cross-sectional survey study. | JPEN J Parenter Enteral Nutr | 2023 |
| 37862822 | Cost-utility analysis of teduglutide compared to standard care in weaning parenteral nutrition support in children with short bowel syndrome. | Clin Nutr | 2023 |
| 37516567 | Assessing the Performance of the Clinician-reported Genetic Testing Utility InDEx (C-GUIDE): Further Evidence of Inter-rater Reliability. | Clin Ther | 2023 |
| 37606004 | Why it is so challenging to perform economic evaluations of interventions in autism and what to do about it. | Autism Res | 2023 |
| 37025514 | A Comparison of Preference-Based, Generic and Disease-Specific Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease. | J Can Assoc Gastroenterol | 2023 |
| 37453830 | Protocol for a Prospective, Observational Cost-effectiveness Analysis of Returning Secondary Findings of Genome Sequencing for Unexplained Suspected Genetic Conditions. | Clin Ther | 2023 |
| 37238445 | Translating Precision Health for Pediatrics: A Scoping Review. | Children (Basel) | 2023 |
| 37004628 | A comparison of the Child Health Utility 9D and the Health Utilities Index for estimating health utilities in pediatric inflammatory bowel disease. | Qual Life Res | 2023 |
| 37264680 | Evaluating the correlations of cost and utility parameters from summary statistics for probabilistic analysis in economic evaluations. | Expert Rev Pharmacoecon Outcomes Res | 2023 |
| 36855223 | Variable patterns of daily activity participation across settings in autistic youth: A latent profile transition analysis. | Autism | 2023 |
| 36598785 | Cost-effectiveness of Universal School- and Community-Based Vision Testing Strategies to Detect Amblyopia in Children in Ontario, Canada. | JAMA Netw Open | 2023 |
| 36493738 | Measuring the association between behavioural services and outcomes in young children with autism spectrum disorder. | Res Dev Disabil | 2023 |
| 36860664 | Infliximab Pricing in International Economic Evaluations in Inflammatory Bowel Disease to Inform Biologic and Biosimilar Access Policies: A Systematic Review. | MDM Policy Pract | 2023 |
| 32801223 | Ethical and Social Values for Paediatric Health Technology Assessment and Drug Policy. | Int J Health Policy Manag | 2022 |
| 35609929 | Comparing genome sequencing technologies to improve rare disease diagnostics: a protocol for the evaluation of a pilot project, Genome-wide Sequencing Ontario. | CMAJ Open | 2022 |
| 35373634 | Developing Economic Models for Assessing the Cost-Effectiveness of Multiple Diagnostic Tests: Methods and Applications. | Med Decis Making | 2022 |
| 35660493 | Carrying the Burden: Informal Care Requirements by Caregivers of Children with Intestinal Failure Receiving Home Parenteral Nutrition. | J Pediatr | 2022 |
| 36512367 | Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension. | JAMA | 2022 |
| 36511921 | Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension. | JAMA | 2022 |
| 36195708 | Applying the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) to genome sequencing: further evidence of validity. | Eur J Hum Genet | 2022 |
| 33704613 | Trajectories of Symptom Severity in Children with Autism: Variability and Turning Points through the Transition to School. | J Autism Dev Disord | 2022 |
| 35219592 | Trio genome sequencing for developmental delay and pediatric heart conditions: A comparative microcost analysis. | Genet Med | 2022 |
| 35098539 | Predictors of language regression and its association with subsequent communication development in children with autism. | J Child Psychol Psychiatry | 2022 |
| 35088428 | "Line care governs our entire world": Understanding the experience of caregivers of children with intestinal failure receiving long-term parenteral nutrition. | JPEN J Parenter Enteral Nutr | 2022 |
| 34906497 | The complexity of diagnosing rare disease: An organizing framework for outcomes research and health economics based on real-world evidence. | Genet Med | 2022 |
| 34906486 | The Clinician-reported Genetic testing Utility InDEx (C-GUIDE): Preliminary evidence of validity and reliability. | Genet Med | 2022 |
| 34906460 | Correspondence on "cost or price of sequencing? implications for economic evaluations in genomic medicine" by Grosse and Gudgeon. | Genet Med | 2022 |
| 35171498 | Considerations for developing regulations for direct-to-consumer genetic testing: a scoping review using the 3-I framework. | J Community Genet | 2022 |
| 35022943 | A Randomized, Community-Based Feasibility Trial of Modified ESDM for Toddlers with Suspected Autism. | J Autism Dev Disord | 2022 |
| 34382216 | Middle-childhood executive functioning mediates associations between early-childhood autism symptoms and adolescent mental health, academic and functional outcomes in autistic children. | J Child Psychol Psychiatry | 2022 |
| 34755325 | Economic evaluations of vision screening to detect amblyopia and refractive errors in children: a systematic review. | Can J Public Health | 2022 |
| 34628597 | Budget Impact Analysis of an Epigenetic Test Used for Diagnosing Fetal Alcohol Spectrum Disorder from the Perspective of a Laboratory Budget Holder in Manitoba, Canada. | Pharmacoecon Open | 2022 |
| 34837153 | Comparing the Impact of Differing Preschool Autism Interventions on Parents in Two Canadian Provinces. | J Autism Dev Disord | 2022 |
| 34687692 | Socioeconomic Status and Vision Care Services in Ontario, Canada: A Population-Based Cohort Study. | J Pediatr | 2022 |
| 34796421 | Training Coaches in Community Agencies to Support Parents of Children with Suspected Autism: Outcomes, Facilitators, and Barriers. | J Autism Dev Disord | 2022 |
| 34043481 | Imputing missing patient-level data and propensity score matching in cost-effectiveness analysis in Crohn's disease. | Expert Rev Pharmacoecon Outcomes Res | 2022 |
| 30601347 | A Cost Analysis of Pulse Oximetry as a Determinant in the Decision to Admit Infants With Mild to Moderate Bronchiolitis. | Pediatr Emerg Care | 2021 |
| 33745119 | Cost-effectiveness of preferred fluids versus electrolytes in pediatric gastroenteritis. | CJEM | 2021 |
| 33925765 | Incorporating Cascade Effects of Genetic Testing in Economic Evaluation: A Scoping Review of Methodological Challenges. | Children (Basel) | 2021 |
| 33925356 | An Assessment of the Validity and Reliability of the Pediatric Child Health Utility 9D in Children with Inflammatory Bowel Disease. | Children (Basel) | 2021 |
| 33532881 | "Best Things": Parents Describe Their Children with Autism Spectrum Disorder Over Time. | J Autism Dev Disord | 2021 |
| 33779740 | Association of Child and Family Attributes With Outcomes in Children With Autism. | JAMA Netw Open | 2021 |
| 33801725 | Utility of Genetic Testing from the Perspective of Parents/Caregivers: A Scoping Review. | Children (Basel) | 2021 |
| 34446836 | Cascade health service use in family members following genetic testing in children: a scoping literature review. | Eur J Hum Genet | 2021 |
| 34828684 | Assessing Value in Child Health. | Children (Basel) | 2021 |
| 34233983 | Coached, Coordinated, Enhanced Neonatal Transition (CCENT): protocol for a multicentre pragmatic randomised controlled trial of transition-to-home support for parents of high-risk infants. | BMJ Open | 2021 |
| 34286396 | Correction to: "Best Things": Parents Describe Their Children with Autism Spectrum Disorder Over Time. | J Autism Dev Disord | 2021 |
| 33110268 | Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies. | Genet Med | 2021 |